Sergio Santillana will become Merrimack Pharmaceuticals Inc.'s chief medical officer on June 12.
Santillana is the former chief medical officer at ARIAD Pharmaceuticals.
Discover more about S&P Global’s offerings
Merrimack names chief medical officer
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
Sergio Santillana will become Merrimack Pharmaceuticals Inc.'s chief medical officer on June 12.
Santillana is the former chief medical officer at ARIAD Pharmaceuticals.